☰

Ozge Uluckan, Ph.D. - Publications

Affiliations: 
2008 Washington University, Saint Louis, St. Louis, MO 
Area:
Cell Biology, Genetics, Oncology
Tree Info Grants Similar researchers PubMed Report error

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Uluçkan Ö. Mouse Models of Melanoma Bone Metastasis. Methods in Molecular Biology (Clifton, N.J.). 1914: 343-348. PMID 30729475 DOI: 10.1007/978-1-4939-8997-3_19  0.422
2018 Luo Y, Grötsch B, Hannemann N, Jimenez M, Ipseiz N, Uluckan O, Lin N, Schett G, Wagner EF, Bozec A. Fra-2 expression in osteoblasts regulates systemic inflammation and lung injury through osteopontin. Molecular and Cellular Biology. PMID 30181393 DOI: 10.1128/Mcb.00022-18  0.428
2016 Uluçkan Ö, Wagner EF. Role of IL-17A signalling in psoriasis and associated bone loss. Clinical and Experimental Rheumatology. 34: 17-20. PMID 27586798  0.309
2016 Uluçkan Ö, Jimenez M, Karbach S, Jeschke A, Graña O, Keller J, Busse B, Croxford AL, Finzel S, Koenders M, van den Berg W, Schinke T, Amling M, Waisman A, Schett G, et al. Chronic skin inflammation leads to bone loss by IL-17-mediated inhibition of Wnt signaling in osteoblasts. Science Translational Medicine. 8: 330ra37. PMID 27089206 DOI: 10.1126/Scitranslmed.Aad8996  0.38
2015 Uluçkan Ö, Segaliny A, Botter S, Santiago JM, Mutsaers AJ. Preclinical mouse models of osteosarcoma. Bonekey Reports. 4: 670. PMID 25987985 DOI: 10.1038/bonekey.2015.37  0.325
2015 Uluçkan Ö, Bakiri L, Wagner EF. Characterization of mouse model-derived osteosarcoma (OS) cells in vitro and in vivo. Methods in Molecular Biology (Clifton, N.J.). 1267: 297-305. PMID 25636475 DOI: 10.1007/978-1-4939-2297-0_14  0.338
2015 Amend SR, Uluckan O, Hurchla M, Leib D, Novack DV, Silva M, Frazier W, Weilbaecher KN. Thrombospondin-1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 30: 106-15. PMID 25042340 DOI: 10.1002/Jbmr.2308  0.726
2012 Su X, Floyd DH, Hughes A, Xiang J, Schneider JG, Uluckan O, Heller E, Deng H, Zou W, Craft CS, Wu K, Hirbe AC, Grabowska D, Eagleton MC, Townsley S, et al. The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling. The Journal of Clinical Investigation. 122: 3579-92. PMID 22996695 DOI: 10.1172/Jci38576  0.73
2012 Uluckan⁎ O, Karbach S, Keller J, Amling M, Waisman A, Wagner E. Epidermal IL-17A leads to bone loss through inhibition of osteoblast differentiation Bone. 50: S31. DOI: 10.1016/J.Bone.2012.02.078  0.354
2009 Uluçkan O, Becker SN, Deng H, Zou W, Prior JL, Piwnica-Worms D, Frazier WA, Weilbaecher KN. CD47 regulates bone mass and tumor metastasis to bone. Cancer Research. 69: 3196-204. PMID 19276363 DOI: 10.1158/0008-5472.Can-08-3358  0.711
2008 Uluçkan O, Eagleton MC, Floyd DH, Morgan EA, Hirbe AC, Kramer M, Dowland N, Prior JL, Piwnica-Worms D, Jeong SS, Chen R, Weilbaecher K. APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice. Journal of Cellular Biochemistry. 104: 1311-23. PMID 18260128 DOI: 10.1002/Jcb.21709  0.722
2008 Uluckan O, Deng H, Prior JL, Piwnica-Worms D, Frazier WA, Weilbaecher KN. P8. Osteoclast dysfunction in CD47−/− mice suppresses metastatic tumor burden and osteolysis Cancer Treatment Reviews. 34: 15-16. DOI: 10.1016/J.Ctrv.2008.03.049  0.456
2008 Floyd D, Wu K, Hirbe A, Uluckan O, Eagleton M, Conley P, Weilbaecher K. P7. The ADP receptor P2Y12 is expressed in developing osteoclasts and is required for full osteoclast function and tumor associated osteolysis Cancer Treatment Reviews. 34: 15. DOI: 10.1016/J.Ctrv.2008.03.048  0.671
2007 Hirbe AC, Rubin J, Uluçkan O, Morgan EA, Eagleton MC, Prior JL, Piwnica-Worms D, Weilbaecher KN. Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in bone. Proceedings of the National Academy of Sciences of the United States of America. 104: 14062-7. PMID 17715292 DOI: 10.1073/Pnas.0705203104  0.75
2007 Hirbe AC, Uluçkan O, Morgan EA, Eagleton MC, Prior JL, Piwnica-Worms D, Trinkaus K, Apicelli A, Weilbaecher K. Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood. 109: 3424-31. PMID 17192391 DOI: 10.1182/Blood-2006-09-048686  0.744
2006 Hirbe A, Morgan EA, Uluçkan O, Weilbaecher K. Skeletal complications of breast cancer therapies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6309s-6314s. PMID 17062720 DOI: 10.1158/1078-0432.Ccr-06-0652  0.644
Show low-probability matches.